Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis

Pathology International

Volumn 54, Issue 4, 2004, Pages 241-250

  Mitani, Osamu ^a,c   Katoh, Masahiro ^b   Shigematsu, Hidekazu ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

^c Maruishi Pharmaceutical Co Ltd   (Japan)

Author keywords

Matrix metalloproteinase; SI 27; Synthetic matrix metalloproteinase inhibitor; Thy 1 nephritis

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; N (N HYDROXY 2 ISOBUTYLSUCCINAMOYL)LEUCYLISOBUTYLAMIDE; SI 27; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLOMERULUS; HISTOPATHOLOGY; MALE; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZYMOGRAPHY;

ACTINS; ANIMALS; ANTIGENS, THY-1; COLLAGEN TYPE I; COLLAGEN TYPE IV; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; MALE; MATRIX METALLOPROTEINASES; OLIGOPEPTIDES; RATS; RATS, WISTAR;

EID: 2442642574     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01615.x     Document Type: Article

References (34)

1. Ishizaki M, Masuda Y, Fukuda Y, Sugisaki Y, Yamanaka N, Masugi Y. Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration of antithymocyte serum. Acta Pathol Jpn 1986; 36: 1191-203.
2. Bagchus WM, Hoedemaeker PhJ, Rozing J, Bakker WW. Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultra-structural study in the rat. Lab Invest 1986; 55: 680-87.
3. Yamamoto T, Wilson CB. Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 1987; 138: 3758-65.
4. Kasahara H. Reconstruction of glomerular tufts-observation of mesangiolysis induced by anti-thymocyte serum. Jpn J Nephrol 1992; 34: 1117-33.
5. Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 1994; 70: 176-82.
6. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-5.
7. Nagase H. Activation mechanism of matrix metalloproteinases. Biol Chem 1997; 378: 151-60.
8. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-54.
9. Adler S, Striker LJ, Striker GE, Perkinson DT, Hibbert J, Couser WG. Studies of progressive glomerular sclerosis in the rat. Am J Pathol 1986; 123: 553-62.
10. Striker LM, Killen PD, Chi E, Striker GE. The composition of glomerulosclerosis. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 1984; 51: 181-91.
11. Floege J, Alpers CE, Burns MW et al. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66: 485-97.
12. Floege J, Johnson RJ, Gordon K et al. Increased synthesis of extracellular matrix mesangial proliferative nephritis. Kidney Int 1991; 40: 477-88.
13. Lovett DH, Johnson RJ, Marti HP, Martin J, Davies M, Couser WG. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 1992; 41: 85-98.
14. Hayashi K, Osada S, Shofuda K, Horikoshi S, Shirato I, Tomino Y. Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis. J Am Soc Nephrol 1998; 9: 2262-71.
15. Shiozawa S. Participation of macrophages in glomerular sclerosis through the expression and activation of matrix metalloproteinase. Pathol Int 2000; 50: 441-57.
16. Davies M, Martin J, Thomas GJ, Lovett DH. Proteinases and glomerular matrix turnover. Kidney Int 1992; 41: 671-8.
17. Zhang L, Nakazawa K, Shigematsu H. Participation of endothelial cells and transformed mesangial cells in remodeling of glomerular capillary loops in Thy-1 nephritis. Pathol Int 2001; 51: 227-39.
18. Iruela-Arispe L, Gordon K, Hugo C et al. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 1995; 147: 1715-27.
19. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995; 47: 114-21.
20. Yagi M, Yamamoto T, Nagano N et al. Transient expression of type I collagen in glomeruli with anti-Thy-1 antibody-induced mesangial proliferative lesions. Pathol Int 1995; 45: 409-14.
21. Kaneko Y, Shiozawa S, Hora K, Nakazawa K. Glomerulosclerosis develops in Thy-1 nephritis under persistent accumulation of macrophages. Pathol Int 2003; 53: 507-17.
22. Madri JA, Williams SK. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol 1983; 97: 153-65.
23. Okuyama A, Naito K. Possible development of matrix metalloproteinase inhibitors as innovative anticancer drugs. Saiboukougaku, Jpn 1998; 17: 561-70.
24. Nakamura Y, Sato K, Wakimoto N, Kimura F, Okuyama A, Motoyoshi K. A new matrix metalloproteinase inhibitor SI-27 induces apoptosis in several human myeloid leukemia to TNF alpha-induced apoptosis. Leukemia 2001; 15: 1217-24.
25. Koike H, Tomioka S, Sorimachi H et al. Membrane-anchored metalloprotease MDC9 has an α-secretase activity responsible for processing the amyloid precursor protein. Biochem J 1999; 343: 371-5.
26. Nguyen M, Arkell J, Jackson CJ. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 2001; 33: 960-70.
27. Haraguchi M, Okamura M, Konishi M et al. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo. Kidney Int 1997; 51: 1838-46.
28. Naito K, Kanbayashi N, Nakajima S et al. Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Int J Cancer 1994; 58: 730-35.
29. Yoshida D, Noha M, Watanabe K, Sugisaki Y, Teramoto A. Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27. Brain Tumor Pathol 2001; 18: 89-100.
30. Johnson RJ, Iida H, Alpers CE et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a maker of mesangial cell proliferation. J Clin Invest 1991; 87: 847-58.
31. Steinmann-Niggli K, Lukes M, Marti HP. Rat mesangial cells and matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation. J Am Soc Nephrol 1997; 8: 395-405.
32. Steinmann-Niggli K, Ziswiler R, Küng M, Marti HP. Inhibition of matrix metalloproteinases attenuates anti-Thy-1.1 nephritis. J Am Soc Nephrol 1998; 9: 397-407.
33. Daniel C, Duffield J, Brunner T, Steinmann-Niggli K, Lods N, Marti HP. Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells. J Pharmacol Exp Ther 2001; 297: 57-68.
34. Hisada Y, Yokoyama H, Kobayashi K. Regulation extracellular matrix metabolism. Kidney Dialysis, Jpn 1999; 47: 221-6.